DEVELOPMENT OF OLIGODENDROCYTES IN THE SPINAL CORD
Project Number1R01NS030800-01A3
Contact PI/Project LeaderMILLER, ROBERT H
Awardee OrganizationCASE WESTERN RESERVE UNIVERSITY
Description
Abstract Text
The neuroepithelium gives rise to all the major classes of cells in the
mature vertebrate CNS including neurons, astrocytes and oligodendrocytes.
In most cases, the regulation of commitment of neuroepithelial cells to a
specific fate and the control of precursor cell migration and
differentiation is unknown. We have demonstrated that oligodendrocyte
precursors in the developing rat spinal cord are initially located only in
ventral regions of the spinal cord and during subsequent development
migrate dorsally where they differentiate into myelin forming cells. More
recently we identified a specific location in the ventral ventricular zone
of the chick spinal cord in which precursors become committed to
oligodendrocytes, and we described a ventral to dorsal gradient of
oligodendrocyte differentiation. These observations led us to propose that
the notochord, a ventrally located transient embryonic structure regulates
the development of spinal cord oligodendrocytes. To determine if signals
from the notochord influence the pattern of oligodendrocyte development,
and whether the notochord is essential for the subsequent development of
spinal cord oligodendrocytes, we will perform notochord transplantation
and ablation studies in chick and Xenopus embryos.
In order to myelinate CNS regions devoid of intrinsic oligodendrocyte
precursors and to ameliorate pathologically demyelinated adult CNS
regions, oligodendrocyte precursors must migrate considerable distances.
We demonstrated that rat optic nerve oligodendrocytes were derived from
progenitor cells that migrated from the brain during development, while
the myelination of the complete spinal cord is dependent on the ventral to
dorsal migration of oligodendrocyte precursors. Based on these studies we
propose that there are-distinct pathways utilized for migration of
oligodendrocyte precursors in the CNS. We have recently developed an
immunolabeling paradigm which for the first time allows us to examine
directly the characteristics of actively migrating oligodendrocyte
precursors in vivo. Using a combination of light and electron microscopic
assays, we will determine the cellular substrates of oligodendrocyte
precursor migration in the intact CNS. Further, to identify the molecular
mechanisms mediating oligodendrocyte precursor migration, in vivo antibody
perturbation studies will be compared with the analysis of oligodendrocyte
precursor migration over defined molecular substrates in vitro. These
studies will provide new and important information on the regulation of
oligodendrocyte development in the vertebrate CNS. Such information is
essential for designing successful approaches to induce remyelination
following injury or demyelinating diseases such as multiple sclerosis.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
077758407
UEI
HJMKEF7EJW69
Project Start Date
01-January-1995
Project End Date
31-December-1997
Budget Start Date
01-January-1995
Budget End Date
31-December-1995
Project Funding Information for 1995
Total Funding
$139,249
Direct Costs
$95,507
Indirect Costs
$43,742
Year
Funding IC
FY Total Cost by IC
1995
National Institute of Neurological Disorders and Stroke
$139,249
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01NS030800-01A3
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01NS030800-01A3
Patents
No Patents information available for 1R01NS030800-01A3
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01NS030800-01A3
Clinical Studies
No Clinical Studies information available for 1R01NS030800-01A3
News and More
Related News Releases
No news release information available for 1R01NS030800-01A3
History
No Historical information available for 1R01NS030800-01A3
Similar Projects
No Similar Projects information available for 1R01NS030800-01A3